Showing results (1121-1130 of 1,160) with videos related to

Sort By:
Pageof 116
Bioorganic & Medicinal Chemistry Letters|August 12, 2006
Synthesis and structure-activity studies of novel benzocycloheptanone oxazolidinone antibacterial agentsJ V N Vara Prasad, Frederick E Boyer, Lou Chupak, et al.
Frontiers in Oncology|July 28, 2025
ACTivity as medicine In Oncology for Head and Neck (ACTIOHN): a feasibility study investigating a patient-centred approach to exercise for head and neck cancer patientsJoanne M Patterson, Mary G Cherry, Andrew Levy, et al.
International Journal of Circumpolar Health|May 8, 2020
The implementation of rifapentine and isoniazid (3HP) in two remote Arctic communities with a predominantly Inuit population, the Taima TB 3HP studyG G Alvarez, D Van Dyk, R Mallick, et al.
Clinical and Experimental Immunology|September 27, 2016
Tolerogenic dendritic cells generated with dexamethasone and vitamin D3 regulate rheumatoid arthritis CD4+ T cells partly via transforming growth factor-β1A E Anderson, D J Swan, O Y Wong, et al.
Regulatory Peptides|June 13, 2006
Effects of acute and chronic relaxin-3 on food intake and energy expenditure in ratsB M McGowan, S A Stanley, K L Smith, et al.
Vaccine|July 18, 2001
Identification of vaccine candidate antigens from a genomic analysis of Porphyromonas gingivalisB C Ross, L Czajkowski, D Hocking, et al.
Biomolecules|May 27, 2026
High-Definition Brain Network (HDBN) Delineation of CDKL5 Deficiency Disorder (CDD) in Genetically Engineered MiceDalton West, Noah William Coulson, Devin Raine Everaldo Cortes, et al.
Biorxiv : the Preprint Server for Biology|September 4, 2023
Disease modification upon brief exposure to tofacitinib during chronic epilepsyOlivia R Hoffman, Jennifer L Koehler, Jose Ezekiel Clemente Espina, et al.
Molecular Cancer Therapeutics|January 1, 2016
Human Leukocyte Antigen-Presented Macrophage Migration Inhibitory Factor Is a Surface Biomarker and Potential Therapeutic Target for Ovarian CancerAndrea M Patterson, Saghar Kaabinejadian, Curtis P McMurtrey, et al.
Science Translational Medicine|March 19, 2025
Disease modification upon 2 weeks of tofacitinib treatment in a mouse model of chronic epilepsyOlivia R Hoffman, Jennifer L Koehler, Jose Ezekiel Clemente Espina, et al.
Pageof 116